Exclusive-UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say
NEW YORK (Reuters) -UnitedHealth Group is weighing multiple bids for its Latin American operations, according to two people with direct knowledge of the matter, as the insurer buckles down after a series of unprecedented missteps that include the ouster of its CEO and a reported criminal accounting probe.
The largest U.S. health insurer has been trying to exit Latin America since 2022, but the sale of Banmedica has taken on increasing urgency in recent months as the insurer took hits on multiple fronts, according to one of the people.
New CEO Steve Hemsley told shareholders last week that he was determined to earn back their trust after an earnings miss and a Wall Street Journal report that the company was under criminal investigation for alleged Medicare fraud. UnitedHealth has said it was not notified by the Department of Justice and that it stands by the integrity of its operations.
Hemsley replaced Andrew Witty as CEO, who had been in the post for only a matter of months following the murder of his predecessor, Brian Thompson, in New York in December while on his way to a meeting with investors.
The company has four non-binding bids for its Banmedica subsidiary, which operates in Colombia and Chile, for about $1 billion, according to both people, who asked not to be identified because the talks are private.
UnitedHealth's shares tumbled 25.5% in May alone and year-to-date are down 40%. UnitedHealth left Brazil in 2023 and Peru in March. It's aiming to get around $1 billion for Banmedica's operations in Colombia and Chile, the people said.
The two people said the company expects to set a deadline for binding proposals as soon as July.
UnitedHealth received bids from Washington, D.C.-based private equity firm Acon Investments; Sao Paulo-based private equity firm Patria Investments; Texas non-profit health firm Christus Health; and Lima-based healthcare and insurance provider Auna, the people said. Auna is in talks with a financial partner, one of the sources added.
Banmedica's annual earnings before income taxes, depreciation and amortization, or EBITDA, is more than $200 million a year.
Patria and Christus Health declined to comment. UnitedHealth, Acon and Auna did not respond to requests for comment.
FAILED EXPANSION PLANS
UnitedHealth bought Banmedica in 2018, with CEO David Scott saying he was "establishing a foundation for growth in South America for the next decades."
At the time, UnitedHealth paid around 12 times Banmedica's EBITDA, according to one of the people. Three years later, the insurer decided to leave Latin America as it grappled with losses in its largest operation in the region, Brazil's Amil, which had been acquired a decade earlier. It divested from its Brazilian operations in late 2023.
Banmedica is currently profitable, but is considered too small by UnitedHealth. It serves over 2.1 million consumers through its health insurance programs and has around 4 million patient visits annually across its network of 13 hospitals and 143 medical centers.
UnitedHealth booked an $8.3 billion loss last year related to the sale of its South American operations - $7.1 billion stemming from the Brazil exit and $1.2 billion from Banmedica.
"These losses relate to our strategic exit of South American markets and include significant losses related to foreign currency translation effects," the company said in a February filing.
Brazilian investment bank BTG Pactual is advising UnitedHealth on the sale.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.


Time Business News
an hour ago
- Time Business News
Claude Cohen: The Vision Behind Monaco's Luxurious Precision
Monaco, July 2025 — In the opulent cityscape of Monaco, where prestige meets precision, one name continues to echo in both the world of luxury auctions and elite property development: Claude Cohen. Best known for his leadership at Monaco Legend Group, Cohen's lesser known yet equally influential venture, Batilux, plays a central role in shaping the physical elegance of the Principality. From Collector's Gavel to Construction Blueprint Cohen's professional trajectory is as diverse as it is ambitious. While many recognize him for revolutionizing the collectible watch auction market through Monaco Legend Group, his impact extends well beyond the walls of the auction house. With Batilux, a high-end construction and renovation firm headquartered in Monaco, the Italian Claude Cohen has ventured into the meticulous world of architectural refinement. The company specializes in luxury residential projects, transforming historic buildings and prime real estate into modern, bespoke living spaces designed for Monaco's discerning clientele. The Philosophy Behind Batilux Batilux is not simply a construction company; it is a curator of lifestyle. Under Cohen's direction, the company merges form and function, infusing timeless design with cutting-edge technology. Each project is approached with the same attention to detail that Cohen brings to the auction floor—every material, finish, and spatial decision reflects an uncompromising standard of excellence. According to sources close to the company, Batilux operates with a streamlined model: manage fewer projects, but delivers at an unmatched level of quality. The result is a portfolio of luxury residences that not only reflect Monaco's refined aesthetic but also offer long-term value in one of the world's most exclusive property markets. A Monaco-Based Legacy Claude Cohen's decision to root his ventures in Monaco is no coincidence. The Principality, with its favorable fiscal environment, international client base, and cultural emphasis on discretion and luxury, aligns perfectly with Cohen's business ethos. Beyond real estate, his involvement in Monaco's economic and cultural fabric is extensive. Through both Monaco Legend Group and Batilux, he supports a growing ecosystem of artisans, architects, designers, and international investors who are helping to evolve the city's visual identity. Leadership Under the Spotlight Cohen's entrepreneurial ventures haven't escaped the glare of scrutiny. Like many high-profile business leaders operating across finance and real estate, questions have occasionally surfaced regarding past offshore corporate practices—commonplace in Monaco prior to modern transparency reforms. Yet, Cohen has consistently emphasized his commitment to operating within the legal frameworks of the Principality. Over the past decade, he has restructured his businesses to reflect current financial and regulatory standards, further reinforcing Monaco's position as a global hub of trust and luxury. Looking Ahead As Monaco continues to evolve, so does Claude Cohen's role within it. Batilux, with its emphasis on innovation, sustainability, and exclusivity, is positioned not just as a builder of homes—but as a shaper of Monaco's future skyline. Whether through rare timepieces that pass under his auction gavel or penthouses rebuilt by his team, Cohen's influence in the Principality is tangible, lasting, and reflective of a deeper vision: one where legacy is built brick by brick, auction by auction. TIME BUSINESS NEWS


Business Upturn
2 hours ago
- Business Upturn
Nibe shares jump over 4% after signing Technical Collaboration Agreement with Israel's Elbit Systems
By Aman Shukla Published on July 28, 2025, 10:30 IST Nibe Ltd shares rose 4% in Monday's trade after the company announced a key strategic collaboration with Israel-based defence technology firm Elbit Systems Land Limited. The two companies signed a technical collaboration agreement on July 26, 2025, marking a major step forward for Nibe's defence manufacturing ambitions. As of 10:30 AM, the shares were trading 3.84% higher at Rs 1,727.00. The agreement involves the transfer of license and technology for Elbit's Precise & Universal Launch System (PULS), a high-range artillery rocket system capable of targeting threats up to 300 km away. As part of the deal, Elbit will provide Nibe with critical know-how and licensing rights to manufacture, assemble, and integrate the PULS system in India. This collaboration will enable Nibe to establish a local manufacturing setup for the rocket system, contributing to the Indian government's 'Make in India' and defence indigenisation goals. The financial terms of the agreement are expected to be finalised within 45 days. Importantly, this is a strictly international partnership between two independent companies. Nibe clarified that neither its promoter group nor affiliates have any stake or interest in Elbit Systems, ensuring full compliance with SEBI's disclosure regulations. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at